NCT00006009View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2001

Study Completion Date

October 31, 2003

Conditions
LymphomaSmall Intestine Cancer
Interventions
BIOLOGICAL

visilizumab

Trial Locations (1)

94305-5408

Stanford University Medical Center, Stanford

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Stanford University

OTHER

NCT00006009 - Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma | Biotech Hunter | Biotech Hunter